de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Talk

Ketamine administration reduces limbic reactivity during emotional stimulation: An fMRI study in healthy subjects

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons84402

Henning,  A
Department High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Scheidegger, M., Grimm S, Walter M, Boeker H, Boesiger P, Seifritz, E., & Henning, A. (2012). Ketamine administration reduces limbic reactivity during emotional stimulation: An fMRI study in healthy subjects. Talk presented at 20th Annual Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine (ISMRM 2012). Melbourne, Australia.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0013-B750-9
Abstract
Many neuroimaging findings are compatible with the hypothesis that limbic hyperactivity during evaluation of emotional stimuli, combined with prefrontal hypoactivity, might cause negative emotional biases in patients suffering from major depressive disorder (MDD) and that this imbalance can be reversed by antidepressant drug treatment. Our findings show that in healthy subjects an antidepressant intravenous dose of ketamine reduces limbic reactivity in the amygdalo-hippocampal complex during an emotional processing task, which is in support of the hypothesis that pharmacologically modulating limbic neurocircuits might be an important therapeutic strategy to restore parts of the disrupted neurobehavioural homeostasis in MDD.